oxazepam has been researched along with Neonatal Abstinence Syndrome in 1 studies
Oxazepam: A benzodiazepine used in the treatment of anxiety, alcohol withdrawal, and insomnia.
oxazepam : A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one substituted by a chloro group at position 7, a hydroxy group at position 3 and phenyl group at position 5.
Neonatal Abstinence Syndrome: Fetal and neonatal addiction and withdrawal as a result of the mother's dependence on drugs during pregnancy. Withdrawal or abstinence symptoms develop shortly after birth. Symptoms exhibited are loud, high-pitched crying, sweating, yawning and gastrointestinal disturbances.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Swortfiguer, D | 1 |
| Cissoko, H | 1 |
| Giraudeau, B | 1 |
| Jonville-Béra, AP | 1 |
| Bensouda, L | 1 |
| Autret-Leca, E | 1 |
1 other study available for oxazepam and Neonatal Abstinence Syndrome
| Article | Year |
|---|---|
[Neonatal consequences of benzodiazepines used during the last month of pregnancy].
Topics: Adult; Benzodiazepines; Drug Monitoring; Female; GABA Modulators; Hospitalization; Humans; Hypoventi | 2005 |